Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Inozyme Pharma Inc (NASDAQ: INZY) was $3.97 for the day, up 0.51% from the previous closing price of $3.95. In other words, the price has increased by $0.51 from its previous closing price. On the day, 1.09 million shares were traded.
Ratios:
Our analysis of INZY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.19 and its Current Ratio is at 2.19. In the meantime, Its Debt-to-Equity ratio is 1.48 whereas as Long-Term Debt/Eq ratio is at 0.65.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on December 12, 2024, initiated with a Outperform rating and assigned the stock a target price of $26.
On September 12, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $16.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 02 ’25 when Treco Douglas A sold 8,819 shares for $0.89 per share. The transaction valued at 7,849 led to the insider holds 41,046 shares of the business.
Stock Price History:
Over the past 52 weeks, INZY has reached a high of $6.24, while it has fallen to a 52-week low of $0.72. The 50-Day Moving Average of the stock is 143.54%, while the 200-Day Moving Average is calculated to be 36.91%.
Shares Statistics:
A total of 64.47M shares are outstanding, with a floating share count of 43.37M. Insiders hold about 32.82% of the company’s shares, while institutions hold 59.45% stake in the company.
